Chapter 14 - Hypertension Flashcards

1
Q

Strongest predictor in terms of BP measurement of cardiovascular risk stratified by age

A

Age < 50 = DBP Age 50-59 = SBP, DBP, PP Age > 60 = SBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rate of renal artery disease in HTN

A

33% has disease 9.6% has > 60% RAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stages of hypertension and SBP/DBP

A

TABLE 14.1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Techniques to measure blood pressure

A

ROUTINE 1) 5 min rest 2) quiet room 3) arm level of heart 4) no caffeine/smk for 30 min 5) BP cuff 80% of arm 6) two measurements AMBULATORY BP monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ambulatory blood pressure monitoring definition

A

HTN = 24hr average > 130/80 daytime average > 140/85

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Definition of white coat hypertension

A

1) elevated BP in physician office > 140/90 2) 24 hr BP < 130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Secondary causes of hypertension and signs and symptoms

A

TABLE 14.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Generation of Ang II

A

Angiotensinogen from liver Renin converts it to angiotensin I ACE converts it to angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NO effects

A

1) vasodilation 2) increase inflammation 3) increase coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lifestyle recommendations to reduce HTN

A

1) weight loss 2) limit Na intake 3) engage aerobic physical activity x 30 min/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Heart outcomes prevention evaluation

A

HOPE study ramipril reduced CV events in patients with HTN and PAD BP < 128/75 is beneficial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SPRINT study

A

9361 patients with HTN and CV risk BP target < 120 is significant better than 140 for MI, ACS, CHF, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Thiazide diuretic key points

A

1) Chlorthalidone, HCT, indapamide, metolazone 2) indication: first line therapy, low renin, black, elderly 3) SE: hyperuricemia, hypokalemia, insulin resistance, erectile dysfunction 4) block sodium and chloride transport in distal convoluted tubule 5) ALLHAT trial shows benefit of thiazide compared to others 6) prevent kidney calcium stones 7) effect reduced by high Na intake and NSAID use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Loop diuretic key points

A

1) Bumetanide, ethacrynic acid, durosemide, torsemide 2) Indicaton: CHF, impaired kidney function 3) SE: hypokalemia, volume depletion MOA: thick ascending limb of LoH block reabsorption of Na, Cl, K associated with SULFA allergic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Potassium-sparing diuretic and aldosterone antagonists

A

1) Amiloride, eplerenone, spironolactone, triamterene 2) indication: hypokalemia from other diuretic, primary aldosteronism, CHF, proteinuria 3) SE: hyperkalemia, GI side effects, gynecomastia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Beta blocker key points

A

1) indicaton: CAD, afib, CHF 2) SE: hyperlipidemia, bradycardia, insulin resistance, depression

17
Q

ACE inhibitor key points

A

1) indication: CAD, CHF, LVH, proteinuria, younger patients 2) SE: angioedema, cough, hyperkalemia, AKI HOPE trial UKPDS trial = benefit of ACE i in HTN and diabetes improve death

18
Q

ARB hey points

A

1) indication: CAD, CHF, LVH, proteinuria 2) SE: angioedema, hyperkalemia, AKI LIFE trial = ARB help with lower CV morbidity/mortality

19
Q

Renin inhibitor key points

A

1) Aliskiren 2) HTN 3) SE: angioedema, hyperkalemia, GI side effects ALTITUDE study - higher risk of CV and renal events - rarely used drug

20
Q

Calcium channel blocker key points

A

Dihydropyridine: amlodipine, felodipine, isradipine, nicardipine, nimodipine, nifedipine Nondihydropyridine: diltiazem, verapamil indication: blacks, elderly SE: LE edema, constipation, bradycardia

21
Q

Alpha blocker key points

A

1) Doxazosin, terazosin 2) indication: HTN, BPH 3) SE: dizziness, fatigue increase risk of heart failure ALLHAT study

22
Q

Central alpha agonist

A

1) clonidine, methyldopa 2) indication: resistant hypertension, pregnancy 3) SE: rebound HTN, fatigue, dry mouth, ED

23
Q

Vasodilators key points

A

1) hydralazine, minoxidil 2) indication: resistant HTN with CHF or impaired renal fxn 3) SE: fluid retention, tachycardia

24
Q

ONTARGET study

A

Combination arb and acei increases AE without benefit

25
Q

Rheos device

A

pulse generator to bilateral carotid to generate carotid massage to reduce Htn

26
Q

symplicity DEVICE

A

decrease renal sympathetic afferent and efferent activity reduces BP